In this study, through the sum of experimental and bioinformatics results, we derived a three‐gene signature (involving LOXL2, CDH1, and FN1), using a risk score calculation based on published microarray data of ESCC specimens. The gene discussed is LOXL2; the disease is esophageal squamous cell carcinoma.